Activation of the renal GLP-1R leads to expression of Ren1 in the renal vascular tree

Endocrinol Diabetes Metab. 2021 Mar 19;4(3):e00234. doi: 10.1002/edm2.234. eCollection 2021 Jul.

Abstract

The GLP-1 receptor (GLP-1R) in the kidney is expressed exclusively in vascular smooth muscle cells in arteries and arterioles. Downstream effects of the activation of the renal vascular GLP-1R are elusive but may involve regulation of the renin-angiotensin-aldosterone system (RAAS). The expression of Ren1 in the mouse renal vasculature was investigated by in situ hybridization after a single subcutaneous dose of liraglutide, semaglutide and after repeated injections of liraglutide. Single and repeated exposure to GLP-1R agonists induced expression of Ren1 in the renal vascular smooth muscle cell compartment compared with vehicle injected controls (p < .0001) for both semaglutide and liraglutide. The present data show a robust induction of Ren1 expression in the vascular smooth muscle cells of the kidney after single and repeated GLP-1R activation and this renin recruitment may be involved in the effects of GLP-1R agonist treatment on kidney disease.

Keywords: GLP‐1; GLP‐1 receptor; GLP‐1R agonists; in situ hybridization; renal vasculature; renin recruitment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Glucagon-Like Peptide-1 Receptor* / agonists
  • Kidney / metabolism
  • Liraglutide* / metabolism
  • Liraglutide* / pharmacology
  • Liraglutide* / therapeutic use
  • Mice
  • Renin / metabolism
  • Renin / pharmacology
  • Renin-Angiotensin System

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Liraglutide
  • Renin